352 related articles for article (PubMed ID: 29856910)
1. Atrophied Brain Lesion Volume: A New Imaging Biomarker in Multiple Sclerosis.
Dwyer MG; Bergsland N; Ramasamy DP; Jakimovski D; Weinstock-Guttman B; Zivadinov R
J Neuroimaging; 2018 Sep; 28(5):490-495. PubMed ID: 29856910
[TBL] [Abstract][Full Text] [Related]
2. A Serial 10-Year Follow-Up Study of Atrophied Brain Lesion Volume and Disability Progression in Patients with Relapsing-Remitting MS.
Zivadinov R; Horakova D; Bergsland N; Hagemeier J; Ramasamy DP; Uher T; Vaneckova M; Havrdova E; Dwyer MG
AJNR Am J Neuroradiol; 2019 Mar; 40(3):446-452. PubMed ID: 30819766
[TBL] [Abstract][Full Text] [Related]
3. Brain atrophy and lesion load predict long term disability in multiple sclerosis.
Popescu V; Agosta F; Hulst HE; Sluimer IC; Knol DL; Sormani MP; Enzinger C; Ropele S; Alonso J; Sastre-Garriga J; Rovira A; Montalban X; Bodini B; Ciccarelli O; Khaleeli Z; Chard DT; Matthews L; Palace J; Giorgio A; De Stefano N; Eisele P; Gass A; Polman CH; Uitdehaag BM; Messina MJ; Comi G; Filippi M; Barkhof F; Vrenken H;
J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1082-91. PubMed ID: 23524331
[TBL] [Abstract][Full Text] [Related]
4. Atrophied Brain T2 Lesion Volume at MRI Is Associated with Disability Progression and Conversion to Secondary Progressive Multiple Sclerosis.
Genovese AV; Hagemeier J; Bergsland N; Jakimovski D; Dwyer MG; Ramasamy DP; Lizarraga AA; Hojnacki D; Kolb C; Weinstock-Guttman B; Zivadinov R
Radiology; 2019 Nov; 293(2):424-433. PubMed ID: 31549947
[TBL] [Abstract][Full Text] [Related]
5. A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis.
Tavazzi E; Bergsland N; Kuhle J; Jakimovski D; Ramanathan M; Maceski AM; Tomic D; Hagemeier J; Kropshofer H; Leppert D; Dwyer MG; Weinstock-Guttman B; Benedict RHB; Zivadinov R
J Neurol; 2020 Mar; 267(3):802-811. PubMed ID: 31768628
[TBL] [Abstract][Full Text] [Related]
6. Glial cell injury and atrophied lesion volume as measures of chronic multiple sclerosis inflammation.
Jakimovski D; Qureshi F; Ramanathan M; Jalaleddini K; Ghoreyshi A; Dwyer MG; Bergsland N; Weinstock-Guttman B; Zivadinov R
J Neurol Sci; 2024 Jun; 461():123055. PubMed ID: 38761669
[TBL] [Abstract][Full Text] [Related]
7. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.
Ge Y; Grossman RI; Udupa JK; Wei L; Mannon LJ; Polansky M; Kolson DL
Radiology; 2000 Mar; 214(3):665-70. PubMed ID: 10715027
[TBL] [Abstract][Full Text] [Related]
8. MRI phenotypes based on cerebral lesions and atrophy in patients with multiple sclerosis.
Tauhid S; Neema M; Healy BC; Weiner HL; Bakshi R
J Neurol Sci; 2014 Nov; 346(1-2):250-4. PubMed ID: 25220114
[TBL] [Abstract][Full Text] [Related]
9. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
Datta G; Colasanti A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Van Vlierberghe E; Van Hecke W; Searle G; Santos-Ribeiro A; Matthews PM
Brain; 2017 Nov; 140(11):2927-2938. PubMed ID: 29053775
[TBL] [Abstract][Full Text] [Related]
10. Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study.
Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Barkhof F; Schoonheim MM; Strijbis EM; Vrenken H; Gallo A; Bisecco A; Ciccarelli O; Yiannakas M; Rovira A; Sastre-Garriga J; Palace J; Matthews L; Gass A; Eisele P; Lukas C; Bellenberg B; Margoni M; Preziosa P; Filippi M;
J Neurol Neurosurg Psychiatry; 2023 Jan; 94(1):10-18. PubMed ID: 36171105
[TBL] [Abstract][Full Text] [Related]
11. Spinal cord atrophy in anterior-posterior direction reflects impairment in multiple sclerosis.
Lundell H; Svolgaard O; Dogonowski AM; Romme Christensen J; Selleberg F; Soelberg Sørensen P; Blinkenberg M; Siebner HR; Garde E
Acta Neurol Scand; 2017 Oct; 136(4):330-337. PubMed ID: 28070886
[TBL] [Abstract][Full Text] [Related]
12. Cervical cord lesion load is associated with disability independently from atrophy in MS.
Kearney H; Altmann DR; Samson RS; Yiannakas MC; Wheeler-Kingshott CA; Ciccarelli O; Miller DH
Neurology; 2015 Jan; 84(4):367-73. PubMed ID: 25540312
[TBL] [Abstract][Full Text] [Related]
13. Central nervous system atrophy predicts future dynamics of disability progression in a real-world multiple sclerosis cohort.
Tsagkas C; Naegelin Y; Amann M; Papadopoulou A; Barro C; Chakravarty MM; Gaetano L; Wuerfel J; Kappos L; Kuhle J; Granziera C; Sprenger T; Magon S; Parmar K
Eur J Neurol; 2021 Dec; 28(12):4153-4166. PubMed ID: 34487400
[TBL] [Abstract][Full Text] [Related]
14. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.
Zivadinov R; Sepcic J; Nasuelli D; De Masi R; Bragadin LM; Tommasi MA; Zambito-Marsala S; Moretti R; Bratina A; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):773-80. PubMed ID: 11385012
[TBL] [Abstract][Full Text] [Related]
15. Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis.
van Walderveen MA; Lycklama A Nijeholt GJ; Adèr HJ; Jongen PJ; Polman CH; Castelijns JA; Barkhof F
Arch Neurol; 2001 Jan; 58(1):76-81. PubMed ID: 11176939
[TBL] [Abstract][Full Text] [Related]
16. Brain lesion location and clinical status 20 years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosis.
Dalton CM; Bodini B; Samson RS; Battaglini M; Fisniku LK; Thompson AJ; Ciccarelli O; Miller DH; Chard DT
Mult Scler; 2012 Mar; 18(3):322-8. PubMed ID: 21878451
[TBL] [Abstract][Full Text] [Related]
17. Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS.
Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Rovira À; Montalban X; Kearney H; Ciccarelli O; Matthews L; Palace J; Gallo A; Bisecco A; Gass A; Eisele P; Lukas C; Bellenberg B; Barkhof F; Vrenken H; Preziosa P; Comi G; Filippi M;
Neurology; 2019 Nov; 93(20):e1852-e1866. PubMed ID: 31611336
[TBL] [Abstract][Full Text] [Related]
18. Gray matter atrophy is related to long-term disability in multiple sclerosis.
Fisniku LK; Chard DT; Jackson JS; Anderson VM; Altmann DR; Miszkiel KA; Thompson AJ; Miller DH
Ann Neurol; 2008 Sep; 64(3):247-54. PubMed ID: 18570297
[TBL] [Abstract][Full Text] [Related]
19. Cortical involvement determines impairment 30 years after a clinically isolated syndrome.
Haider L; Prados F; Chung K; Goodkin O; Kanber B; Sudre C; Yiannakas M; Samson RS; Mangesius S; Thompson AJ; Gandini Wheeler-Kingshott CAM; Ciccarelli O; Chard DT; Barkhof F
Brain; 2021 Jun; 144(5):1384-1395. PubMed ID: 33880511
[TBL] [Abstract][Full Text] [Related]
20. Preferential spinal cord volume loss in primary progressive multiple sclerosis.
Tsagkas C; Magon S; Gaetano L; Pezold S; Naegelin Y; Amann M; Stippich C; Cattin P; Wuerfel J; Bieri O; Sprenger T; Kappos L; Parmar K
Mult Scler; 2019 Jun; 25(7):947-957. PubMed ID: 29781383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
